164 related articles for article (PubMed ID: 12949027)
1. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
Scheid DC; Coleman MT; Hamm RM
J Am Board Fam Pract; 2003; 16(4):270-7. PubMed ID: 12949027
[TBL] [Abstract][Full Text] [Related]
2. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
Armstrong K; Popik S; Guerra C; Ubel PA
Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
[TBL] [Abstract][Full Text] [Related]
3. Influences of hormone replacement therapy on postmenopausal women's health perceptions.
Blümel JE; Castelo-Branco C; Kerrigan N; Cancelo MJ; Blümel B; Haya J; Flores M; Carvajal MC; Sarrá S
Menopause; 2003; 10(3):235-40. PubMed ID: 12792296
[TBL] [Abstract][Full Text] [Related]
4. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
[TBL] [Abstract][Full Text] [Related]
5. Benefits of hormone replacement therapy in postmenopausal women.
Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
[TBL] [Abstract][Full Text] [Related]
6. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
Ness J; Aronow WS; Newkirk E; McDanel D
J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
Roy JA; Sawka CA; Pritchard KI
J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
[TBL] [Abstract][Full Text] [Related]
8. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
10. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
11. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.
Feigelson HS; Jonas CR; Teras LR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):220-4. PubMed ID: 14973094
[TBL] [Abstract][Full Text] [Related]
12. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
Trinh XB; Peeters F; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
[TBL] [Abstract][Full Text] [Related]
13. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
15. Perception of future health risks in mid-aged women: estimates with and without behavioural changes and hormone replacement therapy.
Hunter MS; O'Dea I
Maturitas; 1999 Sep; 33(1):37-43. PubMed ID: 10585172
[TBL] [Abstract][Full Text] [Related]
16. Women's knowledge of and attitudes towards hormone replacement therapy.
Lewin KJ; Sinclair HK; Bond CM
Fam Pract; 2003 Apr; 20(2):112-9. PubMed ID: 12651782
[TBL] [Abstract][Full Text] [Related]
17. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
Welnicka-Jaskiewicz M; Jassem J
Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and breast cancer: revisiting the issues.
DeGregorio MW; Taras TL
J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
[TBL] [Abstract][Full Text] [Related]
20. Predictors of quality of life in peri- and postmenopausal Polish women living in Lublin Voivodeship.
Zołnierczuk-Kieliszek D; Kulik TB; Pacian A
Climacteric; 2011 Dec; 14(6):669-76. PubMed ID: 22017297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
